Covered recipient · General Payments record
GEORGE LANGSTROTH COWAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2021–2025
$2,065.53
- Reported across 222 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $329.35 | 37 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $217.43 | 31 |
| Takeda Pharmaceuticals U.S.A., Inc. | $72.46 | 4 |
| Vanda Pharmaceuticals Inc. | $25.79 | 1 |
| Axsome Therapeutics, Inc. | $13.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1.79 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701045 | CMS |
| ABBVIE INC. | $4.49 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701047 | CMS |
| ABBVIE INC. | $1.79 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701049 | CMS |
| ABBVIE INC. | $7.04 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701051 | CMS |
| ABBVIE INC. | $1.79 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701053 | CMS |
| ABBVIE INC. | $5.06 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701055 | CMS |
| ABBVIE INC. | $4.75 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701057 | CMS |
| ABBVIE INC. | $1.79 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701059 | CMS |
| ABBVIE INC. | $8.86 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701061 | CMS |
| ABBVIE INC. | $101.79 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701063 | CMS |
| ABBVIE INC. | $4.57 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701065 | CMS |
| ABBVIE INC. | $1.79 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701067 | CMS |
| ABBVIE INC. | $5.61 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701069 | CMS |
| ABBVIE INC. | $5.06 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701071 | CMS |
| ABBVIE INC. | $4.68 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701073 | CMS |
| ABBVIE INC. | $1.79 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701075 | CMS |
| ABBVIE INC. | $7.02 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701077 | CMS |
| ABBVIE INC. | $1.79 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701079 | CMS |
| ABBVIE INC. | $1.79 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701081 | CMS |
| ABBVIE INC. | $1.79 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701083 | CMS |
| ABBVIE INC. | $4.95 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701085 | CMS |
| ABBVIE INC. | $7.50 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701087 | CMS |
| ABBVIE INC. | $1.79 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701089 | CMS |
| ABBVIE INC. | $4.95 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701091 | CMS |
| ABBVIE INC. | $4.95 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701093 | CMS |
| ABBVIE INC. | $1.99 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701095 | CMS |
| ABBVIE INC. | $1.99 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701097 | CMS |
| ABBVIE INC. | $5.91 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701099 | CMS |
| ABBVIE INC. | $4.78 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701101 | CMS |
| ABBVIE INC. | $1.79 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701103 | CMS |
| ABBVIE INC. | $1.79 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201701105 | CMS |
| Axsome Therapeutics, Inc. | $13.67 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235449600 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.41 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223835959 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.92 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223856686 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.58 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223816642 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.55 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223862140 | CMS |
| Vanda Pharmaceuticals Inc. | $25.79 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232957619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.